NCT03228927 is a clinical trial of comparison of twin A to twin B in Rosacea, sponsored by The Acne Cure Alliance.

Who is sponsoring NCT03228927?

NCT03228927 is sponsored by The Acne Cure Alliance.

What drugs are being tested in NCT03228927?

Interventions in NCT03228927: comparison of twin A to twin B.

Is NCT03228927 still recruiting?

NCT03228927 is currently status unknown. Last updated 26 July 2017.

Last reviewed 2017-07-26 · How we verify

NCT03228927

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterization of the Facial and Gut Microbiome in Rosacea

Status unknown Last updated 26 July 2017

What this trial tests

trial testing comparison of twin A to twin B in Rosacea in 150 participants. Status unknown.

Timeline

5 August 2017

Primary endpoint
6 August 2017

6 August 2017

Quick facts

Lead sponsor	The Acne Cure Alliance
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	5 August 2017
Primary completion	6 August 2017
Estimated completion	6 August 2017

Drugs / interventions tested

comparison of twin A to twin B

Conditions studied

Rosacea — all drugs for Rosacea →

Sponsor

The Acne Cure Alliance

Who can join

Eligibility, any sex, with Rosacea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Questionnaires will be completed by each member of the twin set. A board-certified dermatologist will examine each member to categorize the type and severity of their rosacea. The facial and gut microbiome will be sampled and sent for microbial analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rosacea

Currently open trials in the same condition.

NCT07296497 — Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety · NA · recruiting
NCT06312813 — Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With · Phase 2 · recruiting
NCT06072066 — Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammatio · NA · recruiting
NCT05942248 — The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis · NA · recruiting
NCT05928169 — Determinants of Chronic Inflammatory Skin Disease Trajectories · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03228927 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Acne Cure Alliance
Last refreshed: 26 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03228927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing